Joan Merrill to Alprostadil
This is a "connection" page, showing publications Joan Merrill has written about Alprostadil.
Connection Strength
0.051
-
Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials. Ann Rheum Dis. 2022 07; 81(7):962-969.
Score: 0.051